Cargando…
Phytalgic(®), a food supplement, vs placebo in patients with osteoarthritis of the knee or hip: a randomised double-blind placebo-controlled clinical trial
INTRODUCTION: The medicinal treatment of osteoarthritis (OA) is mostly symptomatic to relieve pain and incapacity with analgesics and non-steroidal anti-inflammatory drugs (NSAIDs), drugs with well-known risks. Complementary medicines might reduce the symptoms of OA and decrease the need for NSAIDs....
Autores principales: | Jacquet, Alain, Girodet, Pierre-Olivier, Pariente, Antoine, Forest, Karelle, Mallet, Laurent, Moore, Nicholas |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003499/ https://www.ncbi.nlm.nih.gov/pubmed/20015358 http://dx.doi.org/10.1186/ar2891 |
Ejemplares similares
-
Is Phytalgic(® )a goldmine for osteoarthritis patients or is there something fishy about this nutraceutical? A summary of findings and risk-of-bias assessment
por: Christensen, Robin, et al.
Publicado: (2010) -
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis
por: Wandel, Simon, et al.
Publicado: (2010) -
Comparison between intra-articular ozone and placebo in the treatment of knee osteoarthritis: A randomized, double-blinded, placebo-controlled study
por: Lopes de Jesus, Carlos César, et al.
Publicado: (2017) -
The neurologic pain signature responds to nonsteroidal anti-inflammatory treatment vs placebo in knee osteoarthritis
por: López-Solà, Marina, et al.
Publicado: (2022) -
Pulsed electromagnetic fields in knee osteoarthritis: a double blind, placebo-controlled, randomized clinical trial
por: Bagnato, Gian Luca, et al.
Publicado: (2016)